Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5

BACKGROUND: The use of shRNAs to downregulate the expression of specific genes is now relatively routine in experimentation but still hypothetical for clinical application. A potential therapeutic approach for HIV-1 disease is shRNA mediated downregulation of the HIV-1 co-receptor, CCR5. It is incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Saki, Kamata, Masakazu, Kittipongdaja, Panyamol, Chen, Kevin N, Kim, Sanggu, Pang, Shen, Boyer, Joshua, Qin, F Xiao-Feng, An, Dong Sung, Chen, Irvin SY
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701936/
https://www.ncbi.nlm.nih.gov/pubmed/19515239
http://dx.doi.org/10.1186/1479-0556-7-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701936/
https://www.ncbi.nlm.nih.gov/pubmed/19515239
http://dx.doi.org/10.1186/1479-0556-7-8

Ejemplares similares